These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9141135)

  • 1. Structural change and receptor binding in a chemokine mutant with a rearranged disulfide: X-ray structure of E38C/C50AIL-8 at 2 A resolution.
    Eigenbrot C; Lowman HB; Chee L; Artis DR
    Proteins; 1997 Apr; 27(4):556-66. PubMed ID: 9141135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfide bridges in interleukin-8 probed using non-natural disulfide analogues: dissociation of roles in structure from function.
    Rajarathnam K; Sykes BD; Dewald B; Baggiolini M; Clark-Lewis I
    Biochemistry; 1999 Jun; 38(24):7653-8. PubMed ID: 10387004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution.
    Gerber N; Lowman H; Artis DR; Eigenbrot C
    Proteins; 2000 Mar; 38(4):361-7. PubMed ID: 10707023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-8 single-chain homodimers and heterodimers: interactions with chemokine receptors CXCR1, CXCR2, and DARC.
    Leong SR; Lowman HB; Liu J; Shire S; Deforge LE; Gillece-Castro BL; McDowell R; Hébert CA
    Protein Sci; 1997 Mar; 6(3):609-17. PubMed ID: 9070443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monomeric variants of IL-8: effects of side chain substitutions and solution conditions upon dimer formation.
    Lowman HB; Fairbrother WJ; Slagle PH; Kabakoff R; Liu J; Shire S; Hébert CA
    Protein Sci; 1997 Mar; 6(3):598-608. PubMed ID: 9070442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil receptors for interleukin-8 and related CXC chemokines.
    Murphy PM
    Semin Hematol; 1997 Oct; 34(4):311-8. PubMed ID: 9347581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular switch of chemokine receptor selectivity. Chemical modification of the interleukin-8 Leu25 --> Cys mutant.
    Lusti-Narasimhan M; Chollet A; Power CA; Allet B; Proudfoot AE; Wells TN
    J Biol Chem; 1996 Feb; 271(6):3148-53. PubMed ID: 8621714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.
    Jerva LF; Sullivan G; Lolis E
    Protein Sci; 1997 Aug; 6(8):1643-52. PubMed ID: 9260277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities.
    Lowman HB; Slagle PH; DeForge LE; Wirth CM; Gillece-Castro BL; Bourell JH; Fairbrother WJ
    J Biol Chem; 1996 Jun; 271(24):14344-52. PubMed ID: 8662882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8 receptor type A or type B.
    Ben-Baruch A; Bengali K; Tani K; Xu L; Oppenheim JJ; Wang JM
    Cytokine; 1997 Jan; 9(1):37-45. PubMed ID: 9067094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the extracellular binding regions of the human interleukin-8 type B receptor.
    Katancik JA; Sharma A; Radel SJ; De Nardin E
    Biochem Biophys Res Commun; 1997 Mar; 232(3):663-8. PubMed ID: 9126332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution structure of bovine pancreatic trypsin inhibitor with altered binding loop sequence.
    Czapinska H; Otlewski J; Krzywda S; Sheldrick GM; Jaskólski M
    J Mol Biol; 2000 Feb; 295(5):1237-49. PubMed ID: 10653700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfide bonding arrangements in active forms of the somatomedin B domain of human vitronectin.
    Kamikubo Y; De Guzman R; Kroon G; Curriden S; Neels JG; Churchill MJ; Dawson P; Ołdziej S; Jagielska A; Scheraga HA; Loskutoff DJ; Dyson HJ
    Biochemistry; 2004 Jun; 43(21):6519-34. PubMed ID: 15157085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
    Baly DL; Horuk R; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth CM; Gillece-Castro BL; Toy K; Hesselgesser J; Allison DE
    J Immunol; 1998 Nov; 161(9):4944-9. PubMed ID: 9794430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor-ligand interactions measured using time-resolved fluorescence.
    Inglese J; Samama P; Patel S; Burbaum J; Stroke IL; Appell KC
    Biochemistry; 1998 Feb; 37(8):2372-7. PubMed ID: 9485384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-8 derivatives with a reduced potential to form homodimers are fully active in vitro and in vivo.
    Horcher M; Rot A; Aschauer H; Besemer J
    Cytokine; 1998 Jan; 10(1):1-12. PubMed ID: 9505139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations.
    Krieger E; Geretti E; Brandner B; Goger B; Wells TN; Kungl AJ
    Proteins; 2004 Mar; 54(4):768-75. PubMed ID: 14997572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational studies of CXCR1, the receptor of IL-8/CXCL8, using molecular dynamics and electrostatics.
    Huynh N; Mallik B; Zhang L; Martins-Green M; Morikis D
    Biopolymers; 2008 Jan; 89(1):52-61. PubMed ID: 17876799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of cDNA for human interleukin-8 type one receptor in BALB 3T3 fibroblasts and characteristics of products of expression].
    Tikhonov II; Fomin IK; Doroshenko TM; Chalyĭ IuV; Voĭtenok NN
    Mol Biol (Mosk); 1996; 30(5):1014-21. PubMed ID: 8992289
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.
    Lippert U; Artuc M; Grützkau A; Möller A; Kenderessy-Szabo A; Schadendorf D; Norgauer J; Hartmann K; Schweitzer-Stenner R; Zuberbier T; Henz BM; Krüger-Krasagakes S
    J Immunol; 1998 Sep; 161(5):2600-8. PubMed ID: 9725262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.